How Sputnik V Phase 3 Trials Could Transform COVID-19 Vaccine Development
The global race to develop an effective COVID-19 vaccine gained momentum when Russia announced the registration of Sputnik V, developed by the Gamaleya Research Institute. The announcement generated significant international attention and optimism, while also raising questions about clinical transparency and the need for large-scale testing. The next crucial step was the vaccine’s Phase 3...
0 Kommentare 0 Geteilt 10 Ansichten 0 Bewertungen